Copyright © 2000 by the European Society of Cardiology.
Vascular endothelial growth factor release following coronary artery bypass surgery: extracorporeal circulation versus beating heart surgery
a Cardiothoracic Surgery, Imperial College School of Medicine at the National Heart and Lung Institute, London, U.K.
b Cardiac Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, London, U.K.
revised February 28, 2000; accepted March 1, 2000
Abstract
Aims The aim of this study was to examine the circulating levels of vascular endothelial growth factor, following coronary artery bypass graft surgery performed using both standard cardiopulmonary bypass or the octopus technique on the beating heart.
Background Vascular endothelial growth factor has a number of effects that are beneficial in the setting of coronary artery bypass graft surgery including cardioprotection, potent angiogenic activity and amelioration of intimal hyperplasia. Hypoxia is a powerful stimulator of vascular endothelial growth factor expression yet the ability of ischaemia, occurring during coronary artery bypass graft surgery, to induce vascular endothelial growth factor production is unknown.
Methods and Results Serum vascular endothelial growth factor levels were determined in patients undergoing coronary artery bypass graft surgery with standard cardiopulmonary bypass (CPB-CABG group; n=20), with off-pump coronary artery bypass; (OP-CABG; n=12) and in patients undergoing non-cardiac major surgery (n=6). The effect of hypoxia on vascular endothelial growth factor release by neonatal rat cardiac myocytes in vitro was studied.
In the CPB-CABG group vascular endothelial growth factor levels were significantly increased to 78·5±39·3 and 110·5±16·3pg.µl18 and 24h post-operatively, declining to 14·9±9·9pg.µl1by 48h to pre-operative values (14·4±8·6pg.µl1). Significantly higher vascular endothelial growth factor levels were also present in the OP-CABG group 3, 6 and 24h post-operatively (levels 136·6±29·3, 143±26·12pg.µl1and 93·5±20·1pg.µl1, respectively). However, non-cardiac major surgery did not result in elevated vascular endothelial growth factor levels post-operatively (46·36±9·76 vs pre-surgery levels of 26·84±6·1pg.µl1). Either 15min or 3h of hypoxia stimulated vascular endothelial growth factor release from neonatal rat cardiac myocytes in vitro. Twenty-four and 48h post hypoxia, levels of vascular endothelial growth factor were significantly elevated by approximately 17·5- and 48·5-fold respectively.
Conclusions These data demonstrate myocardial ischaemia secondary to CPB-CABG and OP-CABG to be a potent stimulator of vascular endothelial growth factor production, which may have implications for graft endothelialization and cardiovascular haemodynamics post-operatively.
Key Words: Vascular endothelial growth factor, bypass surgery, beating heart
f1 Correspondence: Paul Burton, BSc, MB, BS, PhD, Cardiothoracic Surgery, Imperial College School of Medicine at the National Heart and Lung Institute, Dovehouse Street, London, SW3 6LY.
References
- Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:922
[Abstract/Free Full Text] - Tsurumi Y, Takeshita S, Chen D. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation. 1996;94:32813290
[Abstract/Free Full Text] - Isner JM, Pieczek A, Schainfeld R. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet. 1996;348:370374[CrossRef][Web of Science][Medline]
- Asahara T, Chen D, Tsurumi Y. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation. 1996;94:32913302
[Abstract/Free Full Text] - Van-Belle E, Tio FO, Couffinhal T, Maillard L, Passeri J, Isner JM. Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. Circulation. 1997;95:438448
[Abstract/Free Full Text] - Asahara T, Bauters C, Pastore C. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 1995;91:27932801
[Abstract/Free Full Text] - Forsythe JA, Jiang BH, Iyer NV. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996;16:46044613[Abstract]
- Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol. 1996;270:H18031811
- Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res. 1994;28:11761179
[Abstract/Free Full Text] - Luo Z, Diaco M, Murohara T, Ferrara N, Isner JM, Symes JF. Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann Thorac Surg. 1997;64:993998
[Abstract/Free Full Text] - Seko Y, Takahashi N, Shibuya M, Yazaki Y. Pulsitile stretch stimulates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes. Biochem Biophys Res Commun. 1999;252:462465
- Sadoshima J, Jahn L, Takahashi T, Kulik TJ, Izumo S. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J Biol Chem. 1992;267:1055110560
[Abstract/Free Full Text] - McDouall RM, Page CS, Hafizi S, Yacoub MH, Rose ML. Alloproliferation of purified CD4+ T cells to adult human heart endothelial cells, and study of second-signal requirements. Immunology. 1996;89:220226[CrossRef][Medline]
- Hamdan AD, Aiello LP, Misare BD. Vascular endothelial growth factor expression in canine peripheral vein bypass grafts. J Vasc Surg. 1997;26:7986[CrossRef][Web of Science][Medline]
- Murohara T, Asahara T, Silver M. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101:25672578[Web of Science][Medline]
- Tsurumi Y, Murohara T, Krasinski K. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med. 1997;3:879886[CrossRef][Web of Science][Medline]
- Luo Z, Asahara T, Tsurumi Y, Isner JM, Symes JF. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor. J Vasc Surg. 1998;27:167173[CrossRef][Web of Science][Medline]
- Lopez JJ, Laham RJ, Carrozza JP. Hemodynamic effects of intracoronary VEGF delivery: evidence of tachyphylaxis and NO dependence of response. Am J Physiol. 1997;273:H13171323
- Tofukuji M, Metais C, Li J, Franklin A, Simons M, Sellke FW. Myocardial VEGF expression after cardiopulmonary bypass and cardioplegia. Circulation. 1998;98:II-2426
- Levy AP, Levy NS, Loscalzo J. Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res. 1995;76:758766
[Abstract/Free Full Text] - Thompson NL, Bazoberry F, Speir EH. Transforming growth factor beta-1 in acute myocardial infarction in rats. Growth Factors. 1988;1:9199[Medline]
- Hasdai D, Barak V, Leibovitz E. Serum basic fibroblast growth factor levels in patients with ischemic heart disease. Int J Cardiol. 1997;59:133138[CrossRef][Web of Science][Medline]
- Cuevas P, Barrios V, Gimenez GG. Serum levels of basic fibroblast growth factor in acute myocardial infarction. Eur J Med Res. 1997;2:282284[Medline]
- Seghezzi G, Patel S, Ren CJ. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol. 1998;141:16591673
[Abstract/Free Full Text] - Li J, Hampton T, Morgan JP, Simons M. Stretch-induced VEGF expression in the heart. J Clin Invest. 1997;100:1824[Web of Science][Medline]
- Koh TW, Carr-White G, Desouza AC. Intraoperative cardiac troponin T release and lactate metabolism during coronary artery surgery: comparison of beating heart with conventional coronary artery surgery with cardiopulmonary bypass. Heart. 1999;81:495500
[Abstract/Free Full Text] - Spyridopoulos I, Brogi E, Kearney M. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals. J Mol Cell Cardiol. 1997;29:13211330[CrossRef][Web of Science][Medline]
- Gerber HP, Dixit V, Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem. 1998;273:1331313316
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
D.C Felmeden, A.D Blann, and G.Y.H Lip Angiogenesis: basic pathophysiology and implications for disease Eur. Heart J., April 1, 2003; 24(7): 586 - 603. [Full Text] [PDF] |
||||
![]() |
N.A. Scott, J.L. Knight, B.P. Bidstrup, H. Wolfenden, R.N. Linacre, and G.J. Maddern Systematic review of beating heart surgery with the Octopus(R) Tissue Stabilizer Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 804 - 817. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

